CD56 Antigen

"CD56 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.

Descriptor ID	D019002
MeSH Number(s)	D12.776.395.550.200.250.520.156 D12.776.543.550.200.250.520.156 D23.050.301.264.894.156 D23.050.301.350.250.520.156 D23.101.100.894.156
Concept/Terms	CD56 Antigen CD56 Antigen Antigen, CD56 Leu-19 Antigen Antigen, Leu-19 Leu 19 Antigen Antigens, CD56 NKH-1 Antigen Antigen, NKH-1 NKH 1 Antigen CD56 Antigens

Below are MeSH descriptors whose meaning is more general than "CD56 Antigen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Glycoproteins [D12.776.395]
Membrane Glycoproteins [D12.776.395.550]
Cell Adhesion Molecules [D12.776.395.550.200]
Cell Adhesion Molecules, Neuronal [D12.776.395.550.200.250]
Neural Cell Adhesion Molecules [D12.776.395.550.200.250.520]
CD56 Antigen [D12.776.395.550.200.250.520.156]
Membrane Proteins [D12.776.543]
Membrane Glycoproteins [D12.776.543.550]
Cell Adhesion Molecules [D12.776.543.550.200]
Cell Adhesion Molecules, Neuronal [D12.776.543.550.200.250]
Neural Cell Adhesion Molecules [D12.776.543.550.200.250.520]
CD56 Antigen [D12.776.543.550.200.250.520.156]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Surface [D23.050.301]
Antigens, Differentiation [D23.050.301.264]
Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
CD56 Antigen [D23.050.301.264.894.156]
Cell Adhesion Molecules [D23.050.301.350]
Cell Adhesion Molecules, Neuronal [D23.050.301.350.250]
Neural Cell Adhesion Molecules [D23.050.301.350.250.520]
CD56 Antigen [D23.050.301.350.250.520.156]
Biomarkers [D23.101]
Antigens, Differentiation [D23.101.100]
Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
CD56 Antigen [D23.101.100.894.156]

Below are MeSH descriptors whose meaning is more specific than "CD56 Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "CD56 Antigen" by people in this website by year, and whether "CD56 Antigen" was a major or minor topic of these publications.

Bar chart showing 8 publications over 7 distinct years, with a maximum of 2 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	1	2
2008	0	1	1
2009	1	0	1
2010	1	0	1
2013	0	1	1
2014	0	1	1
2017	0	1	1

Below are the most recent publications written about "CD56 Antigen" by people in Profiles.

Burel JG, Qian Y, Lindestam Arlehamn C, Weiskopf D, Zapardiel-Gonzalo J, Taplitz R, Gilman RH, Saito M, de Silva AD, Vijayanand P, Scheuermann RH, Sette A, Peters B. An Integrated Workflow To Assess Technical and Biological Variability of Cell Population Frequencies in Human Peripheral Blood by Flow Cytometry. J Immunol. 2017 02 15; 198(4):1748-1758.

View in: PubMed
Hughes T, Briercheck EL, Freud AG, Trotta R, McClory S, Scoville SD, Keller K, Deng Y, Cole J, Harrison N, Mao C, Zhang J, Benson DM, Yu J, Caligiuri MA. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep. 2014 Jul 10; 8(1):150-62.

View in: PubMed
Bognet R, Thompson C, Campanelli C. Giant metastatic Merkel cell carcinoma. Skinmed. 2013 May-Jun; 11(3):179-80.

View in: PubMed
Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol. 2010 Aug; 63(2):292-308.

View in: PubMed
Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood. 2010 Jan 14; 115(2):274-81.

View in: PubMed
Burt BM, Plitas G, Nguyen HM, Stableford JA, Bamboat ZM, Dematteo RP. Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function. Hum Immunol. 2008 Aug; 69(8):469-74.

View in: PubMed
Trotta R, Parihar R, Yu J, Becknell B, Allard J, Wen J, Ding W, Mao H, Tridandapani S, Carson WE, Caligiuri MA. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. 2005 Apr 15; 105(8):3011-8.

View in: PubMed
Becknell B, Trotta R, Yu J, Ding W, Mao HC, Hughes T, Marburger T, Caligiuri MA. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. J Immunol Methods. 2005 Jan; 296(1-2):115-23.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement